[Possibilities in the treatment of advanced malignant lymphoma insensitive to the usual combination of cytostatics].
D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001761:Bleomycin / Q000627:therapeutic use*; D055598:Chemical Phenomena; D002621:Chemistry; D004351:Drug Resistance; D004359:Drug Therapy, Combination / Q000009:adverse effects; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy*; D013921:Thrombocytopenia / Q000139:chemically induced; D013997:Time Factors
D000970:Antineoplastic Agents; D001761:Bleomycin
Moznosti lécby pokrocilých zhoubných lymfomů pri ztrátĕ citlivosti na bĕzné kombinace cytostatik